LLY
Eli Lilly and Company
1,152.90$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 32.9% | 35.3% | 38.9% | 42.7% | 46.8% | 34.9% | 37.4% | 37.8% | 36.4% | 40.2% | 41.6% | 49.5% | |
| 10.7% | 10.3% | 11.8% | 14.5% | 16.7% | 5.9% | 7.8% | 7.8% | 4.2% | 4.4% | 4.2% | 6.4% | |
| 13.3% | 12.5% | 15.6% | 17.9% | 16.9% | 6.2% | 7.9% | 8.0% | 4.5% | 4.6% | 4.3% | 6.5% | |
| 10.5% | 11.4% | 12.3% | 11.7% | 13.2% | 14.1% | 14.9% | 16.7% | 17.3% | 17.7% | 16.9% | 17.9% | |
| 7.5% | 9.7% | 9.2% | 9.9% | 7.1% | 8.1% | 8.5% | 8.0% | 8.7% | 9.0% | 9.6% | 12.2% | |
| 21.9% | 22.6% | 21.3% | 19.6% | 20.3% | 20.0% | 18.6% | 18.4% | 20.5% | 20.2% | 21.7% | 23.1% | |
| 4.8% | 11.4% | 10.2% | 9.7% | 3.1% | 9.4% | 8.1% | 8.0% | 8.2% | 7.7% | 7.3% | 5.2% | |
| 7.9% | 14.2% | 11.2% | 9.0% | 2.4% | 16.8% | 16.0% | 15.8% | 14.6% | 10.8% | 7.8% | 5.8% | |
| 57.6% | 59.0% | 63.7% | 74.1% | 75.2% | 93.1% | 87.5% | 81.2% | 78.2% | 83.0% | 81.9% | 76.4% | |
| 30.9% | 23.1% | 28.3% | 32.3% | 27.1% | 30.0% | 26.8% | 30.8% | 34.6% | 42.6% | 36.0% | 31.3% | |
| 7.4% | 0.0% | 5.0% | 8.2% | 2.5% | 3.8% | 0.0% | 3.2% | 3.0% | 10.8% | 6.5% | 1.5% | |
| 3.1% | 3.8% | 3.5% | 3.1% | 2.7% | 3.6% | 3.4% | 3.4% | 3.9% | 4.1% | 4.1% | 4.8% | |
| 14.8% | 22.4% | 21.6% | 22.1% | 26.5% | 35.2% | 35.6% | 31.4% | 29.8% | 28.6% | 36.2% | 36.3% | |
| 42.3% | 41.0% | 36.1% | 25.8% | 24.8% | 6.6% | 12.1% | 18.4% | 21.5% | 16.8% | 18.0% | 23.6% | |
| 45.4% | 45.0% | 41.4% | 30.9% | 26.0% | 12.5% | 16.8% | 18.4% | 20.3% | 16.1% | 17.2% | 21.8% | |
| 3.1% | 3.1% | 2.8% | 2.3% | 2.4% | 2.4% | 2.1% | 2.0% | 1.9% | 1.4% | 1.1% | 0.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.